Global C13 Stable Isotope Labeled Biomolecules Market Insights and Forecast to 2026
- BMR3911164
- 116 Pages
- June 2020
- Healthcare
Prior to COVID-19, the market for C13 Stable Isotope Labeled Biomolecules was anticipated to grow from US$ XX million in 2020 to US$ XX million by 2026; it is expected to grow at a CAGR of XX% during 2021–2026, whereas post-COVID-19 scenario, the market for C13 Stable Isotope Labeled Biomolecules is projected to grow from US$ XX million in 2020 (a change by ~XX% compared to market estimated for 2020 before the outbreak of COVID-19) to US$ XX billion by 2026; it is expected to grow at a CAGR of XX% during 2021–2026. The solicitation of proposals by the governments and public–private companies across the world to mitigate the impact of the COVID-19 pandemic is the key factor propelling the growth of the C13 Stable Isotope Labeled Biomolecules market.
Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost 200 countries around the globe with the World Health Organization declaring it a public health emergency. The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affect the C13 Stable Isotope Labeled Biomolecules market in 2020. The outbreak of COVID-19 has brought effects on many aspects, like flight cancellations; travel bans and quarantines; restaurants closed; all indoor events restricted; over forty countries state of emergency declared; massive slowing of the supply chain; stock market volatility; falling business confidence, growing panic among the population, and uncertainty about future.
This report also analyzes the impact of Coronavirus COVID-19 on the C13 Stable Isotope Labeled Biomolecules industry.
Global C13 Stable Isotope Labeled Biomolecules Scope and Segment
C13 Stable Isotope Labeled Biomolecules market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global C13 Stable Isotope Labeled Biomolecules market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on production capacity, revenue and forecast by Type and by Application for the period 2015-2026.
The following manufacturers are covered in this report:
Cambridge Isotope Laboratories
Sigma-Aldrich
Thermo Fisher Scientific
LGC Standards
Toronto Research Chemicals
IsoLife BV
WITEGA Laboratorien
Omicron Biochemicals
Icon Isotopes
Medical Isotopes
C13 Stable Isotope Labeled Biomolecules Breakdown Data by Type
Medical C13 Stable Isotope Labeled Biomolecules
Others
C13 Stable Isotope Labeled Biomolecules Breakdown Data by Application
Scientific Research
Medical
Industrial
Others
Regional and Country-level Analysis
The C13 Stable Isotope Labeled Biomolecules market is analysed and market size information is provided by regions (countries).
The key regions covered in the C13 Stable Isotope Labeled Biomolecules market report are North America, Europe, China and Japan. It also covers key regions (countries), viz, the U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of production capacity, price and revenue for the period 2015-2026.
Competitive Landscape and C13 Stable Isotope Labeled Biomolecules Market Share Analysis
1.1 C13 Stable Isotope Labeled Biomolecules Product Introduction
1.2 Market Segments
1.3 Key C13 Stable Isotope Labeled Biomolecules Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global C13 Stable Isotope Labeled Biomolecules Market Size Growth Rate by Type
1.4.2 Medical C13 Stable Isotope Labeled Biomolecules
1.4.3 Others
1.5 Market by Application
1.5.1 Global C13 Stable Isotope Labeled Biomolecules Market Size Growth Rate by Application
1.5.2 Scientific Research
1.5.3 Medical
1.5.4 Industrial
1.5.5 Others
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global C13 Stable Isotope Labeled Biomolecules Market Size, Estimates and Forecasts
2.1.1 Global C13 Stable Isotope Labeled Biomolecules Revenue 2015-2026
2.1.2 Global C13 Stable Isotope Labeled Biomolecules Sales 2015-2026
2.2 Global C13 Stable Isotope Labeled Biomolecules, Market Size by Producing Regions: 2015 VS 2020 VS 2026
2.2.1 Global C13 Stable Isotope Labeled Biomolecules Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global C13 Stable Isotope Labeled Biomolecules Retrospective Market Scenario in Revenue by Region: 2015-2020
3 Global C13 Stable Isotope Labeled Biomolecules Competitor Landscape by Players
3.1 C13 Stable Isotope Labeled Biomolecules Sales by Manufacturers
3.1.1 C13 Stable Isotope Labeled Biomolecules Sales by Manufacturers (2015-2020)
3.1.2 C13 Stable Isotope Labeled Biomolecules Sales Market Share by Manufacturers (2015-2020)
3.2 C13 Stable Isotope Labeled Biomolecules Revenue by Manufacturers
3.2.1 C13 Stable Isotope Labeled Biomolecules Revenue by Manufacturers (2015-2020)
3.2.2 C13 Stable Isotope Labeled Biomolecules Revenue Share by Manufacturers (2015-2020)
3.2.3 Global C13 Stable Isotope Labeled Biomolecules Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by C13 Stable Isotope Labeled Biomolecules Revenue in 2019
3.2.5 Global C13 Stable Isotope Labeled Biomolecules Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 C13 Stable Isotope Labeled Biomolecules Price by Manufacturers
3.4 C13 Stable Isotope Labeled Biomolecules Manufacturing Base Distribution, Product Types
3.4.1 C13 Stable Isotope Labeled Biomolecules Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers C13 Stable Isotope Labeled Biomolecules Product Type
3.4.3 Date of International Manufacturers Enter into C13 Stable Isotope Labeled Biomolecules Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global C13 Stable Isotope Labeled Biomolecules Market Size by Type (2015-2020)
4.1.1 Global C13 Stable Isotope Labeled Biomolecules Sales by Type (2015-2020)
4.1.2 Global C13 Stable Isotope Labeled Biomolecules Revenue by Type (2015-2020)
4.1.3 C13 Stable Isotope Labeled Biomolecules Average Selling Price (ASP) by Type (2015-2026)
4.2 Global C13 Stable Isotope Labeled Biomolecules Market Size Forecast by Type (2021-2026)
4.2.1 Global C13 Stable Isotope Labeled Biomolecules Sales Forecast by Type (2021-2026)
4.2.2 Global C13 Stable Isotope Labeled Biomolecules Revenue Forecast by Type (2021-2026)
4.2.3 C13 Stable Isotope Labeled Biomolecules Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global C13 Stable Isotope Labeled Biomolecules Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Market Size by Application (2015-2026)
5.1 Global C13 Stable Isotope Labeled Biomolecules Market Size by Application (2015-2020)
5.1.1 Global C13 Stable Isotope Labeled Biomolecules Sales by Application (2015-2020)
5.1.2 Global C13 Stable Isotope Labeled Biomolecules Revenue by Application (2015-2020)
5.1.3 C13 Stable Isotope Labeled Biomolecules Price by Application (2015-2020)
5.2 C13 Stable Isotope Labeled Biomolecules Market Size Forecast by Application (2021-2026)
5.2.1 Global C13 Stable Isotope Labeled Biomolecules Sales Forecast by Application (2021-2026)
5.2.2 Global C13 Stable Isotope Labeled Biomolecules Revenue Forecast by Application (2021-2026)
5.2.3 Global C13 Stable Isotope Labeled Biomolecules Price Forecast by Application (2021-2026)
6 North America
6.1 North America C13 Stable Isotope Labeled Biomolecules by Country
6.1.1 North America C13 Stable Isotope Labeled Biomolecules Sales by Country
6.1.2 North America C13 Stable Isotope Labeled Biomolecules Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America C13 Stable Isotope Labeled Biomolecules Market Facts & Figures by Type
6.3 North America C13 Stable Isotope Labeled Biomolecules Market Facts & Figures by Application
7 Europe
7.1 Europe C13 Stable Isotope Labeled Biomolecules by Country
7.1.1 Europe C13 Stable Isotope Labeled Biomolecules Sales by Country
7.1.2 Europe C13 Stable Isotope Labeled Biomolecules Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe C13 Stable Isotope Labeled Biomolecules Market Facts & Figures by Type
7.3 Europe C13 Stable Isotope Labeled Biomolecules Market Facts & Figures by Application
8 Asia Pacific
8.1 Asia Pacific C13 Stable Isotope Labeled Biomolecules by Region
8.1.1 Asia Pacific C13 Stable Isotope Labeled Biomolecules Sales by Region
8.1.2 Asia Pacific C13 Stable Isotope Labeled Biomolecules Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific C13 Stable Isotope Labeled Biomolecules Market Facts & Figures by Type
8.3 Asia Pacific C13 Stable Isotope Labeled Biomolecules Market Facts & Figures by Application
9 Latin America
9.1 Latin America C13 Stable Isotope Labeled Biomolecules by Country
9.1.1 Latin America C13 Stable Isotope Labeled Biomolecules Sales by Country
9.1.2 Latin America C13 Stable Isotope Labeled Biomolecules Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America C13 Stable Isotope Labeled Biomolecules Market Facts & Figures by Type
9.3 Central & South America C13 Stable Isotope Labeled Biomolecules Market Facts & Figures by Application
10 Middle East and Africa
10.1 Middle East and Africa C13 Stable Isotope Labeled Biomolecules by Country
10.1.1 Middle East and Africa C13 Stable Isotope Labeled Biomolecules Sales by Country
10.1.2 Middle East and Africa C13 Stable Isotope Labeled Biomolecules Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 U.A.E
10.2 Middle East and Africa C13 Stable Isotope Labeled Biomolecules Market Facts & Figures by Type
10.3 Middle East and Africa C13 Stable Isotope Labeled Biomolecules Market Facts & Figures by Application
11 Company Profiles
11.1 Cambridge Isotope Laboratories
11.1.1 Cambridge Isotope Laboratories Corporation Information
11.1.2 Cambridge Isotope Laboratories Description and Business Overview
11.1.3 Cambridge Isotope Laboratories Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Cambridge Isotope Laboratories C13 Stable Isotope Labeled Biomolecules Products Offered
11.1.5 Cambridge Isotope Laboratories Related Developments
11.2 Sigma-Aldrich
11.2.1 Sigma-Aldrich Corporation Information
11.2.2 Sigma-Aldrich Description and Business Overview
11.2.3 Sigma-Aldrich Sales, Revenue and Gross Margin (2015-2020)
11.2.4 Sigma-Aldrich C13 Stable Isotope Labeled Biomolecules Products Offered
11.2.5 Sigma-Aldrich Related Developments
11.3 Thermo Fisher Scientific
11.3.1 Thermo Fisher Scientific Corporation Information
11.3.2 Thermo Fisher Scientific Description and Business Overview
11.3.3 Thermo Fisher Scientific Sales, Revenue and Gross Margin (2015-2020)
11.3.4 Thermo Fisher Scientific C13 Stable Isotope Labeled Biomolecules Products Offered
11.3.5 Thermo Fisher Scientific Related Developments
11.4 LGC Standards
11.4.1 LGC Standards Corporation Information
11.4.2 LGC Standards Description and Business Overview
11.4.3 LGC Standards Sales, Revenue and Gross Margin (2015-2020)
11.4.4 LGC Standards C13 Stable Isotope Labeled Biomolecules Products Offered
11.4.5 LGC Standards Related Developments
11.5 Toronto Research Chemicals
11.5.1 Toronto Research Chemicals Corporation Information
11.5.2 Toronto Research Chemicals Description and Business Overview
11.5.3 Toronto Research Chemicals Sales, Revenue and Gross Margin (2015-2020)
11.5.4 Toronto Research Chemicals C13 Stable Isotope Labeled Biomolecules Products Offered
11.5.5 Toronto Research Chemicals Related Developments
11.6 IsoLife BV
11.6.1 IsoLife BV Corporation Information
11.6.2 IsoLife BV Description and Business Overview
11.6.3 IsoLife BV Sales, Revenue and Gross Margin (2015-2020)
11.6.4 IsoLife BV C13 Stable Isotope Labeled Biomolecules Products Offered
11.6.5 IsoLife BV Related Developments
11.7 WITEGA Laboratorien
11.7.1 WITEGA Laboratorien Corporation Information
11.7.2 WITEGA Laboratorien Description and Business Overview
11.7.3 WITEGA Laboratorien Sales, Revenue and Gross Margin (2015-2020)
11.7.4 WITEGA Laboratorien C13 Stable Isotope Labeled Biomolecules Products Offered
11.7.5 WITEGA Laboratorien Related Developments
11.8 Omicron Biochemicals
11.8.1 Omicron Biochemicals Corporation Information
11.8.2 Omicron Biochemicals Description and Business Overview
11.8.3 Omicron Biochemicals Sales, Revenue and Gross Margin (2015-2020)
11.8.4 Omicron Biochemicals C13 Stable Isotope Labeled Biomolecules Products Offered
11.8.5 Omicron Biochemicals Related Developments
11.9 Icon Isotopes
11.9.1 Icon Isotopes Corporation Information
11.9.2 Icon Isotopes Description and Business Overview
11.9.3 Icon Isotopes Sales, Revenue and Gross Margin (2015-2020)
11.9.4 Icon Isotopes C13 Stable Isotope Labeled Biomolecules Products Offered
11.9.5 Icon Isotopes Related Developments
11.10 Medical Isotopes
11.10.1 Medical Isotopes Corporation Information
11.10.2 Medical Isotopes Description and Business Overview
11.10.3 Medical Isotopes Sales, Revenue and Gross Margin (2015-2020)
11.10.4 Medical Isotopes C13 Stable Isotope Labeled Biomolecules Products Offered
11.10.5 Medical Isotopes Related Developments
11.1 Cambridge Isotope Laboratories
11.1.1 Cambridge Isotope Laboratories Corporation Information
11.1.2 Cambridge Isotope Laboratories Description and Business Overview
11.1.3 Cambridge Isotope Laboratories Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Cambridge Isotope Laboratories C13 Stable Isotope Labeled Biomolecules Products Offered
11.1.5 Cambridge Isotope Laboratories Related Developments
12 Future Forecast by Regions (Countries) (2021-2026)
12.1 C13 Stable Isotope Labeled Biomolecules Market Estimates and Projections by Region
12.1.1 Global C13 Stable Isotope Labeled Biomolecules Sales Forecast by Regions 2021-2026
12.1.2 Global C13 Stable Isotope Labeled Biomolecules Revenue Forecast by Regions 2021-2026
12.2 North America C13 Stable Isotope Labeled Biomolecules Market Size Forecast (2021-2026)
12.2.1 North America: C13 Stable Isotope Labeled Biomolecules Sales Forecast (2021-2026)
12.2.2 North America: C13 Stable Isotope Labeled Biomolecules Revenue Forecast (2021-2026)
12.2.3 North America: C13 Stable Isotope Labeled Biomolecules Market Size Forecast by Country (2021-2026)
12.3 Europe C13 Stable Isotope Labeled Biomolecules Market Size Forecast (2021-2026)
12.3.1 Europe: C13 Stable Isotope Labeled Biomolecules Sales Forecast (2021-2026)
12.3.2 Europe: C13 Stable Isotope Labeled Biomolecules Revenue Forecast (2021-2026)
12.3.3 Europe: C13 Stable Isotope Labeled Biomolecules Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific C13 Stable Isotope Labeled Biomolecules Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: C13 Stable Isotope Labeled Biomolecules Sales Forecast (2021-2026)
12.4.2 Asia Pacific: C13 Stable Isotope Labeled Biomolecules Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: C13 Stable Isotope Labeled Biomolecules Market Size Forecast by Region (2021-2026)
12.5 Latin America C13 Stable Isotope Labeled Biomolecules Market Size Forecast (2021-2026)
12.5.1 Latin America: C13 Stable Isotope Labeled Biomolecules Sales Forecast (2021-2026)
12.5.2 Latin America: C13 Stable Isotope Labeled Biomolecules Revenue Forecast (2021-2026)
12.5.3 Latin America: C13 Stable Isotope Labeled Biomolecules Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa C13 Stable Isotope Labeled Biomolecules Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: C13 Stable Isotope Labeled Biomolecules Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: C13 Stable Isotope Labeled Biomolecules Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: C13 Stable Isotope Labeled Biomolecules Market Size Forecast by Country (2021-2026)
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter's Five Forces Analysis
13.5 Primary Interviews with Key C13 Stable Isotope Labeled Biomolecules Players (Opinion Leaders)
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 C13 Stable Isotope Labeled Biomolecules Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
Table 1. C13 Stable Isotope Labeled Biomolecules Market Segments
Table 2. Ranking of Global Top C13 Stable Isotope Labeled Biomolecules Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global C13 Stable Isotope Labeled Biomolecules Market Size Growth Rate by Type 2020-2026 (MT) & (US$ Million)
Table 4. Major Manufacturers of Medical C13 Stable Isotope Labeled Biomolecules
Table 5. Major Manufacturers of Others
Table 6. Global C13 Stable Isotope Labeled Biomolecules Market Size Growth Rate by Application 2020-2026 (MT)
Table 7. Global C13 Stable Isotope Labeled Biomolecules Market Size by Region (MT) & (US$ Million): 2020 VS 2026
Table 8. Global C13 Stable Isotope Labeled Biomolecules Sales by Regions 2015-2020 (MT)
Table 9. Global C13 Stable Isotope Labeled Biomolecules Sales Market Share by Regions (2015-2020)
Table 10. Global C13 Stable Isotope Labeled Biomolecules Revenue by Regions 2015-2020 (US$ Million)
Table 11. Global C13 Stable Isotope Labeled Biomolecules Sales by Manufacturers (2015-2020) (MT)
Table 12. Global C13 Stable Isotope Labeled Biomolecules Sales Share by Manufacturers (2015-2020)
Table 13. Global C13 Stable Isotope Labeled Biomolecules Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 14. Global C13 Stable Isotope Labeled Biomolecules by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in C13 Stable Isotope Labeled Biomolecules as of 2019)
Table 15. C13 Stable Isotope Labeled Biomolecules Revenue by Manufacturers (2015-2020) (US$ Million)
Table 16. C13 Stable Isotope Labeled Biomolecules Revenue Share by Manufacturers (2015-2020)
Table 17. Key Manufacturers C13 Stable Isotope Labeled Biomolecules Price (2015-2020) (USD/MT)
Table 18. C13 Stable Isotope Labeled Biomolecules Manufacturers Manufacturing Base Distribution and Headquarters
Table 19. Manufacturers C13 Stable Isotope Labeled Biomolecules Product Type
Table 20. Date of International Manufacturers Enter into C13 Stable Isotope Labeled Biomolecules Market
Table 21. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 22. Global C13 Stable Isotope Labeled Biomolecules Sales by Type (2015-2020) (MT)
Table 23. Global C13 Stable Isotope Labeled Biomolecules Sales Share by Type (2015-2020)
Table 24. Global C13 Stable Isotope Labeled Biomolecules Revenue by Type (2015-2020) (US$ Million)
Table 25. Global C13 Stable Isotope Labeled Biomolecules Revenue Share by Type (2015-2020)
Table 26. C13 Stable Isotope Labeled Biomolecules Average Selling Price (ASP) by Type 2015-2020 (USD/MT)
Table 27. Global C13 Stable Isotope Labeled Biomolecules Sales by Application (2015-2020) (MT)
Table 28. Global C13 Stable Isotope Labeled Biomolecules Sales Share by Application (2015-2020)
Table 29. North America C13 Stable Isotope Labeled Biomolecules Sales by Country (2015-2020) (MT)
Table 30. North America C13 Stable Isotope Labeled Biomolecules Sales Market Share by Country (2015-2020)
Table 31. North America C13 Stable Isotope Labeled Biomolecules Revenue by Country (2015-2020) (US$ Million)
Table 32. North America C13 Stable Isotope Labeled Biomolecules Revenue Market Share by Country (2015-2020)
Table 33. North America C13 Stable Isotope Labeled Biomolecules Sales by Type (2015-2020) (MT)
Table 34. North America C13 Stable Isotope Labeled Biomolecules Sales Market Share by Type (2015-2020)
Table 35. North America C13 Stable Isotope Labeled Biomolecules Sales by Application (2015-2020) (MT)
Table 36. North America C13 Stable Isotope Labeled Biomolecules Sales Market Share by Application (2015-2020)
Table 37. Europe C13 Stable Isotope Labeled Biomolecules Sales by Country (2015-2020) (MT)
Table 38. Europe C13 Stable Isotope Labeled Biomolecules Sales Market Share by Country (2015-2020)
Table 39. Europe C13 Stable Isotope Labeled Biomolecules Revenue by Country (2015-2020) (US$ Million)
Table 40. Europe C13 Stable Isotope Labeled Biomolecules Revenue Market Share by Country (2015-2020)
Table 41. Europe C13 Stable Isotope Labeled Biomolecules Sales by Type (2015-2020) (MT)
Table 42. Europe C13 Stable Isotope Labeled Biomolecules Sales Market Share by Type (2015-2020)
Table 43. Europe C13 Stable Isotope Labeled Biomolecules Sales by Application (2015-2020) (MT)
Table 44. Europe C13 Stable Isotope Labeled Biomolecules Sales Market Share by Application (2015-2020)
Table 45. Asia Pacific C13 Stable Isotope Labeled Biomolecules Sales by Region (2015-2020) (MT)
Table 46. Asia Pacific C13 Stable Isotope Labeled Biomolecules Sales Market Share by Region (2015-2020)
Table 47. Asia Pacific C13 Stable Isotope Labeled Biomolecules Revenue by Region (2015-2020) (US$ Million)
Table 48. Asia Pacific C13 Stable Isotope Labeled Biomolecules Revenue Market Share by Region (2015-2020)
Table 49. Asia Pacific C13 Stable Isotope Labeled Biomolecules Sales by Type (2015-2020) (MT)
Table 50. Asia Pacific C13 Stable Isotope Labeled Biomolecules Sales Market Share by Type (2015-2020)
Table 51. Asia Pacific C13 Stable Isotope Labeled Biomolecules Sales by Application (2015-2020) (MT)
Table 52. Asia Pacific C13 Stable Isotope Labeled Biomolecules Sales Market Share by Application (2015-2020)
Table 53. Latin America C13 Stable Isotope Labeled Biomolecules Sales by Country (2015-2020) (MT)
Table 54. Latin America C13 Stable Isotope Labeled Biomolecules Sales Market Share by Country (2015-2020)
Table 55. Latin Americaa C13 Stable Isotope Labeled Biomolecules Revenue by Country (2015-2020) (US$ Million)
Table 56. Latin America C13 Stable Isotope Labeled Biomolecules Revenue Market Share by Country (2015-2020)
Table 57. Latin America C13 Stable Isotope Labeled Biomolecules Sales by Type (2015-2020) (MT)
Table 58. Latin America C13 Stable Isotope Labeled Biomolecules Sales Market Share by Type (2015-2020)
Table 59. Latin America C13 Stable Isotope Labeled Biomolecules Sales by Application (2015-2020) (MT)
Table 60. Latin America C13 Stable Isotope Labeled Biomolecules Sales Market Share by Application (2015-2020)
Table 61. Middle East and Africa C13 Stable Isotope Labeled Biomolecules Sales by Country (2015-2020) (MT)
Table 62. Middle East and Africa C13 Stable Isotope Labeled Biomolecules Sales Market Share by Country (2015-2020)
Table 63. Middle East and Africa C13 Stable Isotope Labeled Biomolecules Revenue by Country (2015-2020) (US$ Million)
Table 64. Middle East and Africa C13 Stable Isotope Labeled Biomolecules Revenue Market Share by Country (2015-2020)
Table 65. Middle East and Africa C13 Stable Isotope Labeled Biomolecules Sales by Type (2015-2020) (MT)
Table 66. Middle East and Africa C13 Stable Isotope Labeled Biomolecules Sales Market Share by Type (2015-2020)
Table 67. Middle East and Africa C13 Stable Isotope Labeled Biomolecules Sales by Application (2015-2020) (MT)
Table 68. Middle East and Africa C13 Stable Isotope Labeled Biomolecules Sales Market Share by Application (2015-2020)
Table 69. Cambridge Isotope Laboratories Corporation Information
Table 70. Cambridge Isotope Laboratories Description and Major Businesses
Table 71. Cambridge Isotope Laboratories C13 Stable Isotope Labeled Biomolecules Production (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 72. Cambridge Isotope Laboratories Product
Table 73. Cambridge Isotope Laboratories Recent Development
Table 74. Sigma-Aldrich Corporation Information
Table 75. Sigma-Aldrich Description and Major Businesses
Table 76. Sigma-Aldrich C13 Stable Isotope Labeled Biomolecules Production (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 77. Sigma-Aldrich Product
Table 78. Sigma-Aldrich Recent Development
Table 79. Thermo Fisher Scientific Corporation Information
Table 80. Thermo Fisher Scientific Description and Major Businesses
Table 81. Thermo Fisher Scientific C13 Stable Isotope Labeled Biomolecules Production (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 82. Thermo Fisher Scientific Product
Table 83. Thermo Fisher Scientific Recent Development
Table 84. LGC Standards Corporation Information
Table 85. LGC Standards Description and Major Businesses
Table 86. LGC Standards C13 Stable Isotope Labeled Biomolecules Production (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 87. LGC Standards Product
Table 88. LGC Standards Recent Development
Table 89. Toronto Research Chemicals Corporation Information
Table 90. Toronto Research Chemicals Description and Major Businesses
Table 91. Toronto Research Chemicals C13 Stable Isotope Labeled Biomolecules Production (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 92. Toronto Research Chemicals Product
Table 93. Toronto Research Chemicals Recent Development
Table 94. IsoLife BV Corporation Information
Table 95. IsoLife BV Description and Major Businesses
Table 96. IsoLife BV C13 Stable Isotope Labeled Biomolecules Production (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 97. IsoLife BV Product
Table 98. IsoLife BV Recent Development
Table 99. WITEGA Laboratorien Corporation Information
Table 100. WITEGA Laboratorien Description and Major Businesses
Table 101. WITEGA Laboratorien C13 Stable Isotope Labeled Biomolecules Production (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 102. WITEGA Laboratorien Product
Table 103. WITEGA Laboratorien Recent Development
Table 104. Omicron Biochemicals Corporation Information
Table 105. Omicron Biochemicals Description and Major Businesses
Table 106. Omicron Biochemicals C13 Stable Isotope Labeled Biomolecules Production (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 107. Omicron Biochemicals Product
Table 108. Omicron Biochemicals Recent Development
Table 109. Icon Isotopes Corporation Information
Table 110. Icon Isotopes Description and Major Businesses
Table 111. Icon Isotopes C13 Stable Isotope Labeled Biomolecules Production (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 112. Icon Isotopes Product
Table 113. Icon Isotopes Recent Development
Table 114. Medical Isotopes Corporation Information
Table 115. Medical Isotopes Description and Major Businesses
Table 116. Medical Isotopes C13 Stable Isotope Labeled Biomolecules Production (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 117. Medical Isotopes Product
Table 118. Medical Isotopes Recent Development
Table 119. Global C13 Stable Isotope Labeled Biomolecules Sales Forecast by Regions (2021-2026) (MT)
Table 120. Global C13 Stable Isotope Labeled Biomolecules Sales Market Share Forecast by Regions (2021-2026)
Table 121. Global C13 Stable Isotope Labeled Biomolecules Revenue Forecast by Regions (2021-2026) (US$ Million)
Table 122. Global C13 Stable Isotope Labeled Biomolecules Revenue Market Share Forecast by Regions (2021-2026)
Table 123. North America: C13 Stable Isotope Labeled Biomolecules Sales Forecast by Country (2021-2026) (MT)
Table 124. North America: C13 Stable Isotope Labeled Biomolecules Revenue Forecast by Country (2021-2026) (US$ Million)
Table 125. Europe: C13 Stable Isotope Labeled Biomolecules Sales Forecast by Country (2021-2026) (MT)
Table 126. Europe: C13 Stable Isotope Labeled Biomolecules Revenue Forecast by Country (2021-2026) (US$ Million)
Table 127. Asia Pacific: C13 Stable Isotope Labeled Biomolecules Sales Forecast by Region (2021-2026) (MT)
Table 128. Asia Pacific: C13 Stable Isotope Labeled Biomolecules Revenue Forecast by Region (2021-2026) (US$ Million)
Table 129. Latin America: C13 Stable Isotope Labeled Biomolecules Sales Forecast by Country (2021-2026) (MT)
Table 130. Latin America: C13 Stable Isotope Labeled Biomolecules Revenue Forecast by Country (2021-2026) (US$ Million)
Table 131. Middle East and Africa: C13 Stable Isotope Labeled Biomolecules Sales Forecast by Country (2021-2026) (MT)
Table 132. Middle East and Africa: C13 Stable Isotope Labeled Biomolecules Revenue Forecast by Country (2021-2026) (US$ Million)
Table 133. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 134. Key Challenges
Table 135. Market Risks
Table 136. Main Points Interviewed from Key C13 Stable Isotope Labeled Biomolecules Players
Table 137. C13 Stable Isotope Labeled Biomolecules Customers List
Table 138. C13 Stable Isotope Labeled Biomolecules Distributors List
Table 139. Research Programs/Design for This Report
Table 140. Key Data Information from Secondary Sources
Table 141. Key Data Information from Primary Sources
List of Figures
Figure 1. C13 Stable Isotope Labeled Biomolecules Product Picture
Figure 2. Global C13 Stable Isotope Labeled Biomolecules Sales Market Share by Type in 2020 & 2026
Figure 3. Medical C13 Stable Isotope Labeled Biomolecules Product Picture
Figure 4. Others Product Picture
Figure 5. Global C13 Stable Isotope Labeled Biomolecules Sales Market Share by Application in 2020 & 2026
Figure 6. Scientific Research
Figure 7. Medical
Figure 8. Industrial
Figure 9. Others
Figure 10. C13 Stable Isotope Labeled Biomolecules Report Years Considered
Figure 11. Global C13 Stable Isotope Labeled Biomolecules Market Size 2015-2026 (US$ Million)
Figure 12. Global C13 Stable Isotope Labeled Biomolecules Sales 2015-2026 (MT)
Figure 13. Global C13 Stable Isotope Labeled Biomolecules Market Size Market Share by Region: 2020 Versus 2026
Figure 14. Global C13 Stable Isotope Labeled Biomolecules Sales Market Share by Region (2015-2020)
Figure 15. Global C13 Stable Isotope Labeled Biomolecules Sales Market Share by Region in 2019
Figure 16. Global C13 Stable Isotope Labeled Biomolecules Revenue Market Share by Region (2015-2020)
Figure 17. Global C13 Stable Isotope Labeled Biomolecules Revenue Market Share by Region in 2019
Figure 18. Global C13 Stable Isotope Labeled Biomolecules Sales Share by Manufacturer in 2019
Figure 19. The Top 10 and 5 Players Market Share by C13 Stable Isotope Labeled Biomolecules Revenue in 2019
Figure 20. C13 Stable Isotope Labeled Biomolecules Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 21. Global C13 Stable Isotope Labeled Biomolecules Sales Market Share by Type (2015-2020)
Figure 22. Global C13 Stable Isotope Labeled Biomolecules Sales Market Share by Type in 2019
Figure 23. Global C13 Stable Isotope Labeled Biomolecules Revenue Market Share by Type (2015-2020)
Figure 24. Global C13 Stable Isotope Labeled Biomolecules Revenue Market Share by Type in 2019
Figure 25. Global C13 Stable Isotope Labeled Biomolecules Market Share by Price Range (2015-2020)
Figure 26. Global C13 Stable Isotope Labeled Biomolecules Sales Market Share by Application (2015-2020)
Figure 27. Global C13 Stable Isotope Labeled Biomolecules Sales Market Share by Application in 2019
Figure 28. Global C13 Stable Isotope Labeled Biomolecules Revenue Market Share by Application (2015-2020)
Figure 29. Global C13 Stable Isotope Labeled Biomolecules Revenue Market Share by Application in 2019
Figure 30. North America C13 Stable Isotope Labeled Biomolecules Sales Growth Rate 2015-2020 (MT)
Figure 31. North America C13 Stable Isotope Labeled Biomolecules Revenue Growth Rate 2015-2020 (US$ Million)
Figure 32. North America C13 Stable Isotope Labeled Biomolecules Sales Market Share by Country in 2019
Figure 33. North America C13 Stable Isotope Labeled Biomolecules Revenue Market Share by Country in 2019
Figure 34. U.S. C13 Stable Isotope Labeled Biomolecules Sales Growth Rate (2015-2020) (MT)
Figure 35. U.S. C13 Stable Isotope Labeled Biomolecules Revenue Growth Rate (2015-2020) (US$ Million)
Figure 36. Canada C13 Stable Isotope Labeled Biomolecules Sales Growth Rate (2015-2020) (MT)
Figure 37. Canada C13 Stable Isotope Labeled Biomolecules Revenue Growth Rate (2015-2020) (US$ Million)
Figure 38. North America C13 Stable Isotope Labeled Biomolecules Market Share by Type in 2019
Figure 39. North America C13 Stable Isotope Labeled Biomolecules Market Share by Application in 2019
Figure 40. Europe C13 Stable Isotope Labeled Biomolecules Sales Growth Rate 2015-2020 (MT)
Figure 41. Europe C13 Stable Isotope Labeled Biomolecules Revenue Growth Rate 2015-2020 (US$ Million)
Figure 42. Europe C13 Stable Isotope Labeled Biomolecules Sales Market Share by Country in 2019
Figure 43. Europe C13 Stable Isotope Labeled Biomolecules Revenue Market Share by Country in 2019
Figure 44. Germany C13 Stable Isotope Labeled Biomolecules Sales Growth Rate (2015-2020) (MT)
Figure 45. Germany C13 Stable Isotope Labeled Biomolecules Revenue Growth Rate (2015-2020) (US$ Million)
Figure 46. France C13 Stable Isotope Labeled Biomolecules Sales Growth Rate (2015-2020) (MT)
Figure 47. France C13 Stable Isotope Labeled Biomolecules Revenue Growth Rate (2015-2020) (US$ Million)
Figure 48. U.K. C13 Stable Isotope Labeled Biomolecules Sales Growth Rate (2015-2020) (MT)
Figure 49. U.K. C13 Stable Isotope Labeled Biomolecules Revenue Growth Rate (2015-2020) (US$ Million)
Figure 50. Italy C13 Stable Isotope Labeled Biomolecules Sales Growth Rate (2015-2020) (MT)
Figure 51. Italy C13 Stable Isotope Labeled Biomolecules Revenue Growth Rate (2015-2020) (US$ Million)
Figure 52. Russia C13 Stable Isotope Labeled Biomolecules Sales Growth Rate (2015-2020) (MT)
Figure 53. Russia C13 Stable Isotope Labeled Biomolecules Revenue Growth Rate (2015-2020) (US$ Million)
Figure 54. Europe C13 Stable Isotope Labeled Biomolecules Market Share by Type in 2019
Figure 55. Europe C13 Stable Isotope Labeled Biomolecules Market Share by Application in 2019
Figure 56. Asia Pacific C13 Stable Isotope Labeled Biomolecules Sales Growth Rate 2015-2020 (MT)
Figure 57. Asia Pacific C13 Stable Isotope Labeled Biomolecules Revenue Growth Rate 2015-2020 (US$ Million)
Figure 58. Asia Pacific C13 Stable Isotope Labeled Biomolecules Sales Market Share by Region in 2019
Figure 59. Asia Pacific C13 Stable Isotope Labeled Biomolecules Revenue Market Share by Region in 2019
Figure 60. China C13 Stable Isotope Labeled Biomolecules Sales Growth Rate (2015-2020) (MT)
Figure 61. China C13 Stable Isotope Labeled Biomolecules Revenue Growth Rate (2015-2020) (US$ Million)
Figure 62. Japan C13 Stable Isotope Labeled Biomolecules Sales Growth Rate (2015-2020) (MT)
Figure 63. Japan C13 Stable Isotope Labeled Biomolecules Revenue Growth Rate (2015-2020) (US$ Million)
Figure 64. South Korea C13 Stable Isotope Labeled Biomolecules Sales Growth Rate (2015-2020) (MT)
Figure 65. South Korea C13 Stable Isotope Labeled Biomolecules Revenue Growth Rate (2015-2020) (US$ Million)
Figure 66. India C13 Stable Isotope Labeled Biomolecules Sales Growth Rate (2015-2020) (MT)
Figure 67. India C13 Stable Isotope Labeled Biomolecules Revenue Growth Rate (2015-2020) (US$ Million)
Figure 68. Australia C13 Stable Isotope Labeled Biomolecules Sales Growth Rate (2015-2020) (MT)
Figure 69. Australia C13 Stable Isotope Labeled Biomolecules Revenue Growth Rate (2015-2020) (US$ Million)
Figure 70. Taiwan C13 Stable Isotope Labeled Biomolecules Sales Growth Rate (2015-2020) (MT)
Figure 71. Taiwan C13 Stable Isotope Labeled Biomolecules Revenue Growth Rate (2015-2020) (US$ Million)
Figure 72. Indonesia C13 Stable Isotope Labeled Biomolecules Sales Growth Rate (2015-2020) (MT)
Figure 73. Indonesia C13 Stable Isotope Labeled Biomolecules Revenue Growth Rate (2015-2020) (US$ Million)
Figure 74. Thailand C13 Stable Isotope Labeled Biomolecules Sales Growth Rate (2015-2020) (MT)
Figure 75. Thailand C13 Stable Isotope Labeled Biomolecules Revenue Growth Rate (2015-2020) (US$ Million)
Figure 76. Malaysia C13 Stable Isotope Labeled Biomolecules Sales Growth Rate (2015-2020) (MT)
Figure 77. Malaysia C13 Stable Isotope Labeled Biomolecules Revenue Growth Rate (2015-2020) (US$ Million)
Figure 78. Philippines C13 Stable Isotope Labeled Biomolecules Sales Growth Rate (2015-2020) (MT)
Figure 79. Philippines C13 Stable Isotope Labeled Biomolecules Revenue Growth Rate (2015-2020) (US$ Million)
Figure 80. Vietnam C13 Stable Isotope Labeled Biomolecules Sales Growth Rate (2015-2020) (MT)
Figure 81. Vietnam C13 Stable Isotope Labeled Biomolecules Revenue Growth Rate (2015-2020) (US$ Million)
Figure 82. Asia Pacific C13 Stable Isotope Labeled Biomolecules Market Share by Type in 2019
Figure 83. Asia Pacific C13 Stable Isotope Labeled Biomolecules Market Share by Application in 2019
Figure 84. Latin America C13 Stable Isotope Labeled Biomolecules Sales Growth Rate 2015-2020 (MT)
Figure 85. Latin America C13 Stable Isotope Labeled Biomolecules Revenue Growth Rate 2015-2020 (US$ Million)
Figure 86. Latin America C13 Stable Isotope Labeled Biomolecules Sales Market Share by Country in 2019
Figure 87. Latin America C13 Stable Isotope Labeled Biomolecules Revenue Market Share by Country in 2019
Figure 88. Mexico C13 Stable Isotope Labeled Biomolecules Sales Growth Rate (2015-2020) (MT)
Figure 89. Mexico C13 Stable Isotope Labeled Biomolecules Revenue Growth Rate (2015-2020) (US$ Million)
Figure 90. Brazil C13 Stable Isotope Labeled Biomolecules Sales Growth Rate (2015-2020) (MT)
Figure 91. Brazil C13 Stable Isotope Labeled Biomolecules Revenue Growth Rate (2015-2020) (US$ Million)
Figure 92. Argentina C13 Stable Isotope Labeled Biomolecules Sales Growth Rate (2015-2020) (MT)
Figure 93. Argentina C13 Stable Isotope Labeled Biomolecules Revenue Growth Rate (2015-2020) (US$ Million)
Figure 94. Latin America C13 Stable Isotope Labeled Biomolecules Market Share by Type in 2019
Figure 95. Latin America C13 Stable Isotope Labeled Biomolecules Market Share by Application in 2019
Figure 96. Middle East and Africa C13 Stable Isotope Labeled Biomolecules Sales Growth Rate 2015-2020 (MT)
Figure 97. Middle East and Africa C13 Stable Isotope Labeled Biomolecules Revenue Growth Rate 2015-2020 (US$ Million)
Figure 98. Middle East and Africa C13 Stable Isotope Labeled Biomolecules Sales Market Share by Country in 2019
Figure 99. Middle East and Africa C13 Stable Isotope Labeled Biomolecules Revenue Market Share by Country in 2019
Figure 100. Turkey C13 Stable Isotope Labeled Biomolecules Sales Growth Rate (2015-2020) (MT)
Figure 101. Turkey C13 Stable Isotope Labeled Biomolecules Revenue Growth Rate (2015-2020) (US$ Million)
Figure 102. Saudi Arabia C13 Stable Isotope Labeled Biomolecules Sales Growth Rate (2015-2020) (MT)
Figure 103. Saudi Arabia C13 Stable Isotope Labeled Biomolecules Revenue Growth Rate (2015-2020) (US$ Million)
Figure 104. U.A.E C13 Stable Isotope Labeled Biomolecules Sales Growth Rate (2015-2020) (MT)
Figure 105. U.A.E C13 Stable Isotope Labeled Biomolecules Revenue Growth Rate (2015-2020) (US$ Million)
Figure 106. Middle East and Africa C13 Stable Isotope Labeled Biomolecules Market Share by Type in 2019
Figure 107. Middle East and Africa C13 Stable Isotope Labeled Biomolecules Market Share by Application in 2019
Figure 108. North America C13 Stable Isotope Labeled Biomolecules Sales Growth Rate Forecast (2021-2026) (MT)
Figure 109. North America C13 Stable Isotope Labeled Biomolecules Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 110. Europe C13 Stable Isotope Labeled Biomolecules Sales Growth Rate Forecast (2021-2026) (MT)
Figure 111. Europe C13 Stable Isotope Labeled Biomolecules Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 112. Asia Pacific C13 Stable Isotope Labeled Biomolecules Sales Growth Rate Forecast (2021-2026) (MT)
Figure 113. Asia Pacific C13 Stable Isotope Labeled Biomolecules Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 114. Latin America C13 Stable Isotope Labeled Biomolecules Sales Growth Rate Forecast (2021-2026) (MT)
Figure 115. Latin America C13 Stable Isotope Labeled Biomolecules Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 116. Middle East and Africa C13 Stable Isotope Labeled Biomolecules Sales Growth Rate Forecast (2021-2026) (MT)
Figure 117. Middle East and Africa C13 Stable Isotope Labeled Biomolecules Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 118. Porter's Five Forces Analysis
Figure 119. Channels of Distribution
Figure 120. Distributors Profiles
Figure 121. Bottom-up and Top-down Approaches for This Report
Figure 122. Data Triangulation
Figure 123. Key Executives Interviewed
Similar Reports
The global digital pathology market was valued at $3,323 million in 2016, and is expected to reach $8,668 million by 2023, registering a CAGR of 14.8% during the forecast period. Digital pathology is defined as an image-based information setting enabled b...
- Publish Date: February 26, 2018
- $5370
The global regenerative medicine market was valued at $5,444 million in 2016, and is estimated to reach $39,325 million by 2023, registering a CAGR of 32.2% from 2017 to 2023. Regenerative medicines are used to repair, replace, and regenerate tissues & organs that are affected owin...
- Publish Date: May 29, 2018
- $5370
The medical robotics and computer-assisted surgery is a combination of equipment, accessories, software, and services that aid in performing different functions, such as robotic minimally invasive and non-invasive radiosurgeries, rehabilitation therapies, and hospital & pharmacy automation. Surgical robotics...
- Publish Date: May 1, 2016
- $5370
